Misonix and Mentor prolong ultrasound agreement
This article was originally published in Clinica
Executive Summary
Minimally-invasive ultrasound specialist Misonix and Mentor, a firm focused on developing medical devices for the aesthetics market, have extended a distribution agreement for the former’s Lysonix 3000 ultrasound-assisted liposuction system. The deal, which prolongs a previous agreement struck in September 2007 by one year, sees Mentor retain exclusive distribution rights to the Lysonix system in the US and gain non-exclusive rights to the technology for certain unspecified foreign markets. According to Farmingdale, New York-based Misonix, the agreement includes minimum purchase requirements which represent “significant growth over the previous year”. Exact financial terms of the extension were not disclosed.